Litigation/Liability Trends
Wildfires Rage in Australia, Ravaging Sydney’s Air Quality
Sydney is world famous for its shimmering harbor and clear blue skies. Not this summer. As bushfires ravage the country's east coast, pollution is becoming a regular occurrence in Australia's biggest ...
Driverless Auto Development Spreads as Hyundai Commits Billions Toward Development
Hyundai Motor Co. will spend 20 trillion won ($17 billion) over the next six years on new technology to help make the switch to electric and autonomous vehicles. Announcing its strategic plan to ...
Risks Rise Significantly for Company Execs Seeking D&O Cover
The range of risks facing company executives, or directors and officers (D&Os), has increased significantly in recent years along with resulting insurance claims, according to a report published ...
Facing Thousands of Lawsuits, J&J Claims New Tests Show Asbestos-Free Baby Powder
Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the ...
U.S. Regions Struggling With Opioids Pursue Own Lawsuits, Ditch Class Action
Local governments in regions hard hit by the U.S. opioid epidemic have opted out of massive litigation taking aim at the drug industry over the crisis, potentially weakening a novel legal mechanism ...
Volkswagen Confronts Giant UK Emissions Class Action Lawsuit
Volkswagen AG is facing one of the largest-ever U.K. class action lawsuits, with almost 100,000 vehicle owners accusing it of misleading them by installing emissions-cheating software that made it ...
U.S. Prosecutors to Pursue Criminal Probe of 6 Pharma Companies Over Opioid Shipments
Federal prosecutors are investigating six pharmaceutical companies for potential criminal charges in connection with shipping big quantities of opioid painkillers that contributed to a healthcare ...
Appeals Court Upholds $70M Verdict Against J&J Over Risperdal Side Effects
A Pennsylvania appeals court upheld a $70 million verdict against Johnson & Johnson in a lawsuit charging its Risperdal anti-psychotic drug caused a man to grow female breasts and also ruled that ...